Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_assertion type Assertion NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_head.
- NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_assertion description "[Women with HLA-B*44, HLA-B*51, or HLA-B*57 who were infected with the HPV16 E6 variant L83V had an approximately four- to fivefold increased risk for cancer compared with controls (odds ratio [OR] = 3.5, 95% CI = 1.1-11.1, OR = 4.2, 95% CI = 1.19-14.69, or OR = 4.67, 95% CI = 1.2-18.6, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_provenance.
- NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_assertion evidence source_evidence_literature NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_provenance.
- NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_assertion SIO_000772 12691704 NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_provenance.
- NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_assertion wasDerivedFrom befree-20140225 NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_provenance.
- NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_assertion wasGeneratedBy ECO_0000203 NP775318.RA99R0owkVk_evroNpkw8j3eWHZCTLPeM0GQCWPAGgzMQ130_provenance.